ANI Pharma (ANIP) Reports Q3 Loss of $0.37/sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to ANI Pharma (ANIP) Reports Q3 Loss of $0.37/sh

ANI Pharmaceuticals Reports Third Quarter 2021 Results

November 1, 2021 6:45 AM EDT

-- Third quarter 2021 net revenues of $52.1 million; net loss of $4.4 million and diluted loss per share of ($0.37) --

-- Third quarter adjusted non-GAAP EBITDA of $16.6 million and adjusted non-GAAP diluted earnings per share of $1.01 --

-- FDA approves supplemental new drug application for Purified Cortrophin Gel for the treatment of certain chronic autoimmune disorders; full-scale launch planned for early Q1 2022 --

-- Acquisition of Novitium Pharma LLC is expected to close in November 2021 --

-- Launched Nebivolol Tablets... More